Last edition
News about "opioid-induced constipation "
Grunenthal Announces Acquisition of Valinor Pharma
Grünenthal has acquired Valinor Pharma and its product Movantik (naloxegol), with a total deal value of approx. USD 250 million, inclusive of all royalty obligations. <br />
Opioid-induced Constipation | 23/07/2024 | By Aishwarya | 325
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members